Search results
Results From The WOW.Com Content Network
Clomipramine, sold under the brand name Anafranil among others, is a tricyclic antidepressant (TCA). [7] It is used in the treatment of various conditions, most notably obsessive–compulsive disorder but also many other disorders, including hyperacusis, panic disorder, major depressive disorder, trichotillomania, [8] body dysmorphic disorder [9] [10] [11] and chronic pain. [7]
Bradycardia; Hypertension (high blood pressure); Allergic reactions (e.g. dyspnoea (shortness of breath), bronchospasm, wheezing, angioneurotic oedema) Anaphylaxis; Changes in appetite
Prucalopride has been given orally to ~2700 patients with chronic constipation in controlled clinical trials. The most frequently reported side effects are headache and gastrointestinal symptoms (abdominal pain, nausea or diarrhea). Such reactions occur predominantly at the start of therapy and usually disappear within a few days with continued ...
The most frequent side effects, occurring in 20% or more of users, are dry mouth, drowsiness, dizziness, constipation, and weight gain (on average 1.8 kg [60]). [23] Other common side effects are headache problems ( amblyopia , blurred vision), tachycardia , increased appetite, tremor , fatigue/ asthenia /feeling slowed down, and dyspepsia .
The most prevalent side effects include nausea, mild sedation, fatigue, and dizziness. At higher dosages, there is an increased risk for restlessness, insomnia, and tremors. [6] Cariprazine was approved for medical use in the United States in September 2015. [12] It was approved as a generic medication in 2022, [13] but is covered by patents ...
However, it does act as a high affinity antagonist of the histamine H 1 receptor [24] and is a low to moderate affinity antagonist of the dopamine D 2, serotonin 5-HT 2, and α 1-adrenergic receptors. [3] [23] H 1 receptor antagonism accounts for its antihistamine effects and associated sedative side effects.
The rate of incidence of side effects of moclobemide is low, [23] with insomnia, headache and dizziness being the most commonly reported side effects in the initial stages of therapy with moclobemide. [57] Moclobemide, even at high doses of 600 mg, does not impair the ability to drive a motor vehicle.
Oral tablets containing 12.5 mg doxylamine succinate as well as oral capsules containing 25 mg doxylamine succinate were also previously available but were discontinued. [22] The combination of doxylamine and pyridoxine is available in the form of extended-and delayed-release oral tablets containing 10 to 20 mg doxylamine succinate and 10 to 20 ...